Published in Cancer Detect Prev on January 01, 2005
The relationship between early embryo development and tumourigenesis. J Cell Mol Med (2010) 1.12
Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. Autoimmun Rev (2006) 1.00
Diagnostic value of multiple tumor markers for patients with esophageal carcinoma. PLoS One (2015) 0.91
Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Oncol Lett (2012) 0.86
Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol (2015) 0.86
Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis. PLoS One (2012) 0.84
Calreticulin is a B cell molecular target in some gastrointestinal malignancies. Clin Exp Immunol (2009) 0.83
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer. FEBS Open Bio (2015) 0.78
Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma. Oncol Lett (2015) 0.76
Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol (2005) 5.52
A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell (2002) 5.34
CIP2A inhibits PP2A in human malignancies. Cell (2007) 5.28
Synthetic gene networks that count. Science (2009) 4.54
The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA (2003) 4.40
A bottom-up approach to gene regulation. Nature (2006) 4.03
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis (2013) 3.99
Diversity-based, model-guided construction of synthetic gene networks with predicted functions. Nat Biotechnol (2009) 3.86
Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. J Clin Psychiatry (2015) 3.46
GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J Cell Sci (2004) 3.31
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica. Neurology (2013) 3.13
miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J Biol Chem (2009) 2.68
Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J Clin Invest (2007) 2.40
Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 2.14
MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun (2009) 2.12
Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol (2006) 2.11
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum (2012) 2.09
The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J (2006) 2.04
Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene (2002) 1.95
Formation of GW bodies is a consequence of microRNA genesis. EMBO Rep (2006) 1.92
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch Neurol (2007) 1.86
Small interfering RNA-mediated silencing induces target-dependent assembly of GW/P bodies. Mol Biol Cell (2007) 1.83
The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem (2009) 1.74
Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia. Eur J Immunol (2010) 1.72
Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res (2003) 1.72
Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med (2010) 1.70
The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing. RNA (2009) 1.69
Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol (2005) 1.69
Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Ann Neurol (2011) 1.67
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys (2005) 1.66
The role of GW/P-bodies in RNA processing and silencing. J Cell Sci (2007) 1.63
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. Cancer Cell (2012) 1.61
Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol (2010) 1.58
Identification of GW182 and its novel isoform TNGW1 as translational repressors in Ago2-mediated silencing. J Cell Sci (2008) 1.53
Tuning and controlling gene expression noise in synthetic gene networks. Nucleic Acids Res (2010) 1.52
Transurethral vapor enucleation and resection of the prostate with plasma vaporization button electrode for the treatment of benign prostatic hyperplasia: a feasibility study. J Endourol (2012) 1.50
Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells. PLoS One (2011) 1.47
QSPR/QSAR models for prediction of the physicochemical properties and biological activity of polybrominated diphenyl ethers. Chemosphere (2006) 1.46
Identification and network of outer membrane proteins regulating streptomysin resistance in Escherichia coli. J Proteome Res (2008) 1.42
Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism (2007) 1.40
2-Hydr-oxy-N'-[(E)-(3-hydr-oxy-2-naphth-yl)methyl-ene]benzohydrazide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.40
Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. J Immunol (2005) 1.35
Autoimmune targeting of key components of RNA interference. Arthritis Res Ther (2006) 1.32
Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics (2006) 1.32
Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol (2009) 1.30
Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer (2010) 1.27
Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum (2005) 1.27
Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum (2004) 1.26
Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182. J Mol Med (Berl) (2003) 1.25
Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. Jpn J Clin Oncol (2005) 1.25
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 1.23
Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur J Immunol (2011) 1.22
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease. Blood (2008) 1.21
Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods (2006) 1.20
Polymicrobial infection with periodontal pathogens specifically enhances microRNA miR-146a in ApoE-/- mice during experimental periodontal disease. Infect Immun (2011) 1.20
Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate (2005) 1.19
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One (2012) 1.19
MicroRNAs and their emerging roles in immunology. Ann N Y Acad Sci (2008) 1.18
High-resolution N(6) -methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing. Angew Chem Int Ed Engl (2014) 1.18
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp Neurol (2009) 1.18
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett (2009) 1.16
Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212. J Immunol (2012) 1.16
Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A (2014) 1.16
Antinuclear antibody test: when to order? Am J Med (2013) 1.16
Mind wandering in Chinese daily lives--an experience sampling study. PLoS One (2012) 1.15
Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. Oncol Rep (2006) 1.15
The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J Neurosci (2011) 1.14
Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum (2006) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res (2008) 1.13
MicroRNAs and autoimmunity. Curr Opin Immunol (2012) 1.12
Revisiting the Kinnel-Scheuer hypothesis for the biosynthesis of palau'amine. Chem Commun (Camb) (2010) 1.12
Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res (2002) 1.12
Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol (2013) 1.12
PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model. Brain Res (2008) 1.11
Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. J Proteome Res (2011) 1.11
Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Antivir Ther (2011) 1.11
Natural killer cells in human autoimmunity. Curr Opin Immunol (2009) 1.11
FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA. Nat Commun (2013) 1.10
Comparison of clonogenic assay with premature chromosome condensation assay in prediction of human cell radiosensitivity. World J Gastroenterol (2006) 1.10
Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. J Immunol (2008) 1.10
High resolution of microRNA signatures in human whole saliva. Arch Oral Biol (2011) 1.09
A panel of monoclonal antibodies to cytoplasmic GW bodies and the mRNA binding protein GW182. Hybrid Hybridomics (2003) 1.09
Brightness analysis by Z-scan fluorescence fluctuation spectroscopy for the study of protein interactions within living cells. Biophys J (2010) 1.09
Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer (2007) 1.08